Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 10/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 10/20 | 0.40 |
| ▸ | MLYCD | O95822 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.35 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21504706 | 0.93 | EGFR (0.39) | EGFRERBB2L3MBTL1MLYCDCNR2 | |
| SCHEMBL20014046 | 0.88 | ESRRG (0.38) | EGFRERBB2L3MBTL1NR1H2NR1H3 | |
| SCHEMBL20014047 | 0.88 | MEN1 (0.40) | L3MBTL1NR1H2NR1H3CNR2GAA | |
| SCHEMBL20014043 | 0.87 | MLYCD (0.33) | MLYCDALDH1A1 | |
| SCHEMBL20014045 | 0.83 | ALDH1A1 (0.45) | L3MBTL1GAALMNACYP3A4KDM4E | |
| SCHEMBL22694292 | 0.77 | LMNA (0.41) | NR1H2LMNACYP1A2CYP2D6KDM4E | |
| SCHEMBL15216391 | 0.77 | EGFR (0.41) | EGFRERBB2L3MBTL1NR1H2NR1H3 | |
| SCHEMBL25476288 | 0.76 | PTPRB (0.32) | LMNAALDH1A1POLB | |
| SCHEMBL18473354 | 0.76 | USP5 (0.38) | L3MBTL1LMNACYP3A4CYP2D6KDM4E | |
| SCHEMBL15216322 | 0.76 | L3MBTL1 (0.45) | EGFRERBB2L3MBTL1NR1H2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10754248-B2 | Sulfonium salt, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-08-25 | — | — | US | disclosed |
| US-20200249571-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-08-06 | — | — | US | disclosed |
| US-10180626-B2 | Sulfonium salt, resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-01-15 | — | — | US | disclosed |
| US-20180088464-A1 | SULFONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200249571-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | PAG1, LIFR, GIGYF2 | EGFR 2497/4885ERBB2 4713/4885L3MBTL1 2851/4885 |
| US-20180088464-A1 | SULFONIUM SALT, RESIST COMPOSITION, AND PATTERNING PROCESS | LSM14A, PAG1, EWSR1 | EGFR 1907/4885ERBB2 4715/4885L3MBTL1 2427/4885 |
| US-10180626-B2 | Sulfonium salt, resist composition, and patterning process | LSM14A, PAG1, EWSR1 | EGFR 1907/4885ERBB2 4715/4885L3MBTL1 2427/4885 |
| US-10754248-B2 | Sulfonium salt, resist composition, and patterning process | GPS1, SPIN2B, SPIN1 | EGFR 927/4885ERBB2 2571/4885L3MBTL1 3409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.